Liver transplantation for symptomatic liver metastases of neuroendocrine tumours

Current Oncology

Volumn 19, Issue 4, 2012, Pages 217-221

  Chan, G ^a   Kocha, W ^b   Reid, R ^b   Taqi, A ^b   Wall, W ^b   Quan, D ^b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Liver metastases; Liver transplantation; Neuroendocrine tumour

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CAPECITABINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; KI 67 ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OCTREOTIDE; PENTETREOTIDE IN 111; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ABDOMINAL SCINTISCANNING; ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURGERY; CANCER THERAPY; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HEPATIC ARTERY; HORMONE RELEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LIVER METASTASIS; LIVER TRANSPLANTATION; LUMBAR SPINE; MALE; MESENTERY; NEUROENDOCRINE TUMOR; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PROTEIN BLOOD LEVEL; RADIOISOTOPE THERAPY; RECURRENT DISEASE; RETRANSPLANTATION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84865169624     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.19.950     Document Type: Article

References (15)

1. Steinmüller T, Kianmanesh R, Falconi M, et al. On behalf of the Frascati Consensus Conference participants. Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2008;87:47-62.
2. Madoff DC, Gupta S, Ahrar K, Murthy R, Yao JC. Update on the management of neuroendocrine hepatic metastases. J Vasc Interv Radiol 2006;17:1235-49.
3. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation 1998;66:1307-12.
4. Rosenau J, Bahr MJ, von Wasielewski R, et al. Ki67, Ecadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002;73:386-94.
5. Frilling A, Malago M, Weber F, et al. Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients. Liver Transpl 2006;12:1089-96.
6. van Vilsteren FG, Baskin-Bey ES, Nagorney DM, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl 2006;12:448-56.
7. Olausson M, Friman S, Herlenius G, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl 2007;13:327-33.
8. Le Treut YP, Grégoire E, Belghiti J, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant 2008;8:1205-13.
9. Gedaly R, Daily MF, Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the unos database. Arch Surg 2011;146:953-8.
10. Máthé Z, Tagkalos E, Paul A, et al. Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: a survival-based analysis. Transplantation 2011;91:575-82.
11. Nguyen NT, Harring TR, Goss JA, O'Mahony CA. Neuroendocrine liver metastases and orthotopic liver transplantation: the U.S. experience. Int J Hepatol 2011;2011:742890.
12. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010;39:707-12.
13. Pavel M, Baudin E, Couvelard A, et al. On behalf of the Barcelona Consensus Conference participants. enets Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2012;95:157-76.
14. Lang H, Oldhafer KJ, Weimann A, et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997;225:347-54.
15. Yao JC, Shah MH, Ito T, et al. On behalf of the RAD001 in Advanced Neuroendocrine Tumors, Third Trial (radiant-3) Study Group. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364:514-23.